Back to Journals » Journal of Asthma and Allergy » Volume 14

Corrigendum

Profile of Anti-IL-5 mAb Mepolizumab in the Treatment of Severe Refractory Asthma and Hypereosinophilic Diseases [Corrigendum]

       
Total article views   HTML views PDF downloads Totals
2,626 Dovepress* 2,534+ 325 2,859
PubMed Central* 92 45 137
Totals 2,626 370 2,996
*Since 29 June 2021

View citations on PubMed Central and Google Scholar